Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Compare Immunogenicity, Safety and Long-term Booster Response After Primary Vaccination With 2 Intradermal Doses Versus 3 Intradermal Doses of PCEC Rabies Vaccine (Rabipur) in Healthy School Children in Thailand (5-8 Years of Age)

NCT01107275 is registered in ClinicalTrials.gov with Provincial Public Health Office, Phetchabun as lead sponsor.

NCT NCT01107275
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01107275 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Compare Immunogenicity, Safety and Long-term Booster Response After Primary Vaccination With 2 Intradermal Doses Versus 3 Intradermal Doses of PCEC Rabies Vaccine (Rabipur) in Healthy School Children in Thailand (5-8 Years of Age)
Lead sponsor
Provincial Public Health Office, Phetchabun
Phase
Phase 3
Overall status
Completed
Start date
November 30, 2002
Completion date
November 30, 2008
Enrollment
703 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

rabies prevention